Hi, I'm CNBC producer Katie Kramer, one of the voices behind the CNBC podcast SquawkPod.

In these times of uncertainty, we want to make sure we're bringing you, our listeners, as much information as possible, as quickly as we can.

That's why we're sharing with you now a CNBC special report, Markets and Turmoil.

Listen in.

Good. CNBC's special report, markets and turmoil. Listen in. Good evening. I'm Scott Wapner on day 116 of the coronavirus crisis, as Georgia is now just

hours away from reopening its economy.

Potentially bad news for Gilead's drug Remdesivir.

New questions about the drug that many hoped would get us out of this mess.

Plus,

Safe and phased reopening of our economy does not mean that we are letting down our guard.

It's now just a matter of hours before Georgia tests the waters and goes back to work.

Also tonight.

They are victimizing our community in my citizens, and that's just absolutely offensive to me.

A new threat to the nation's meat supply.

This CNBC special report, markets in turmoil, starts right now. Here's Scott Wapner.

Good to have you with us. Once again this evening, let's take you right to the boards and show you where

futures look at this hour. We are negative across the board, Dow, with a triple-digit loss right now.

Interesting session today on Wall Street. Today, really one

company changed the tone in the session, and it was Gilead. Stocks gave up gains after a negative

report on Gilead's drug designed to fight the virus. We'll have more on that in just a moment. The

Dow rising 39 points. It had been up more than 400 at the highs today, the S&P 500 and the

NASDAQ ending slightly lower. Well, in a matter of hours, Georgia is set to reopen its economy.

...